Evidence map›Paper›PMID 24071801›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2014

Processes and factors involved in decisions regarding return of incidental genomic findings in research.

Robert Klitzman, Brigitte Buquez, Paul S Appelbaum, Abby Fyer, Wendy K Chung

Open access · greenAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Views of adults living with sickle cell disease on the theoretical return of secondary genomic findings.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  3. Article
  4. Experiences and perspectives on the return of secondary findings among genetic epidemiologists.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  5. Normative and conceptual ELSI research: what it is, and why it's important.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Informed consent for return of incidental findings in genomic research.Genetics in medicine : official journal of the American College of Medical Genetics · 2014
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Robert KlitzmanDepartment of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York, New York, USA.
Brigitte BuquezDepartment of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York, New York, USA.
Paul S AppelbaumDepartment of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York, New York, USA.
Abby FyerDepartment of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York, New York, USA.
Wendy K Chung1] Department of Pediatrics, Columbia University Medical Center, New York, New York, USA [2] Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Columbia University Irving Medical Center · US

Funding

Center for Research on the Ethical, Legal and Social Implications of Psychiatric, Neurologic and Behavioral GeneticsP50HG007257 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI APPELBAUM, PAUL STUART · 2013 to 2017
$5.4M
Impact of return of incidental genetic test results to research participants in tR01HG006600 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHUNG, WENDY K, PHELAN, JO C · 2011 to 2013
$2.1M
Center for ELSI Research on Psychiatric Neurologic and Behavioral GeneticsP20HG005535 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI APPELBAUM, PAUL STUART · 2010 to 2012
$731k
Challenges of Informed Consent in Return of Data from Genomic ResearchR21HG006596 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI APPELBAUM, PAUL STUART · 2011 to 2012
$400k
NHGRI NIH HHS P20 HG005535NHGRI NIH HHS P20 HG005535-02NHGRI NIH HHS P50 HG007257NHGRI NIH HHS R01 HG006600NHGRI NIH HHS R21 HG006596
6 · The paper itself

Abstract

purposeStudies have begun exploring whether researchers should return incidental findings in genomic studies, and if so, which findings should be returned; however, how researchers make these decisions-the processes and factors involved-has remained largely unexplored.

methodsWe interviewed 28 genomics researchers in-depth about their experiences and views concerning the return of incidental findings.

resultsResearchers often struggle with questions concerning which incidental findings to return and how to make those decisions. Multiple factors shape their views, including information about the gene variant (e.g., pathogenicity and disease characteristics), concerns about participants' well-being and researcher responsibility, and input from external entities. Researchers weigh the evidence, yet they face conflicting pressures, with relevant data frequently being unavailable. Researchers vary in who they believe should decide: participants, principal investigators, institutional review boards, and/or professional organizations. Contextual factors can influence these decisions, including policies governing return of results by institutions and biobanks and the study design. Researchers vary in desires for: guidance from institutions and professional organizations, changes to current institutional processes, and community-wide genetics education.

conclusionThese data, the first to examine the processes by which researchers make decisions regarding the return of genetic incidental findings, highlight several complexities involved and have important implications for future genetics research, policy, and examinations of these issues.

Indexed as

Incidental FindingsDecision MakingDisclosureEthics Committees, ResearchGenetic ResearchGenome, HumanGenomicsHumansResearch Personnel

Identifiers

PMID24071801
PMCPMC3966970
OpenAlexW2006137942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.